Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS (Details Narrative)

v3.22.2.2
EQUITY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 10, 2022
Apr. 02, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Jan. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Proceeds from warrant exercises           $ 1,170,110        
Common stock, shares authorized 500,000,000 500,000,000   500,000,000   500,000,000       500,000,000  
Common stock, shares outstanding 477,610     477,610   477,610       166,394  
Conversion of stock shares 438,776 438,776       438,776          
Conversion of stock, description           As a result of the Reverse Stock Split, the Series A Preferred Stock is convertible at a ratio of one thousand shares of Series A Preferred Stock into one share of common stock          
Share based compensation, stock option granted           54,750        
Share based compensation, stock option vested           5,125 14,417        
Share based compensation, stock option exercise price           $ 70.00        
Share-based compensation recognized       $ 120,448 $ 162,359 $ 535,481 $ 1,024,359        
Share based payment award options outstanding 29,635     29,635 29,635 29,635 29,635     29,635 410
Share based payment award options outstanding vested 20,510     20,510 14,802 20,510 14,802        
Stock-based compensation expense       $ 61,000 $ 162,000 $ 246,000 $ 1,024,000        
Unrecognized compensation costs $ 206,000     $ 206,000   $ 206,000          
Weighted average period           2 years 2 months 1 day          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount           495,026 900,907        
Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount           384,788 22,608        
Stock Options [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount           29,635 29,635        
Series A Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Preferred stock, shares outstanding 438,776,170     438,776,170   438,776,170       501,887,534  
Conversion of Stock, Shares Issued       55,802,949   63,111,364          
Preferred stock, voting rights           Holders of Series A Preferred Stock (“Series A Holders”) have the right to receive notice of any meeting of holders of common stock and to vote upon any matter submitted to a vote of the holders of common stock. Each Series A Holder shall vote on each matter on an as converted basis submitted to them with the holders of common stock          
Conversion of stock, description           converts to common stock at a one-for-one thousand ratio immediately upon request of the Series A Holder          
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, shares outstanding 477,610     477,610   477,610          
Common Stock [Member] | Series A Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Conversion of Stock, Shares Issued       55,805   63,114          
Warrant Holders [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price of warrant $ 14.00     $ 14.00   $ 14.00   $ 14.00 $ 14.00    
Warrant term               5 years 5 years    
Exercise on aggregate of warrants 83,579     83,579   83,579          
Proceeds from warrant exercises           $ 1,170,000          
Directors and Officers [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share based compensation, stock option granted     54,750                
Share based compensation, stock option vested     4,750                
Share based compensation, stock option exercise price     $ 70.00                
Chief Executive Officer [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share-based compensation recognized             $ 205,000